State AZ
Clinical Trials in Arizona
Recruiting clinical trials with at least one study location in Arizona. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arizona
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
NCT05885698 N/A
Recruiting
MYLUNG Consortium Part 3: Observational Study
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
7,500 pts
Location
United States
Sponsor
US Oncology Research
NCT06667700 Phase 3
Recruiting
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Dise...
Condition
Coronavirus Disease (COVID-19)
Enrollment
3,082 pts
Location
United States, Argentina, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT01915511 N/A
Recruiting
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes...
Condition
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Enrollment
3,000 pts
Location
United States
Sponsor
Duke University
NCT04906434 Phase 1
Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in ...
Condition
Advanced Liver Cancer
Enrollment
200 pts
Location
United States, China, Taiwan
Sponsor
Abbisko Therapeutics Co, Ltd
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04736667 N/A
Recruiting
Mitral Valve Screening Survey
Condition
Mitral Valve Disease
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Medstar Health Research Instit
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
NCT07161999 Phase 2
Recruiting
Study of COYA 302 for the Treatment of ALS
Condition
Amyotrophic Lateral Sclerosis (ALS)
Enrollment
120 pts
Location
United States, Canada
Sponsor
Coya Therapeutics
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05920798 Phase 1, Phase 2
Recruiting
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube,...
Condition
Fallopian Tube Carcinosarcoma
Enrollment
40 pts
Location
United States
Sponsor
Mayo Clinic
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
1,000 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
NCT06087224 N/A
Recruiting
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Res...
Condition
Death; Neonatal
Enrollment
947 pts
Location
United States, Canada
Sponsor
Mayo Clinic
NCT06568692 Phase 2
Recruiting
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metast...
Condition
Breast Cancer
Enrollment
90 pts
Location
United States
Sponsor
Processa Pharmaceuticals
NCT07332000 Phase 2
Recruiting
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagen...
Condition
Prostate Cancer Patients Treated by Radiotherapy
Enrollment
45 pts
Location
United States
Sponsor
Candel Therapeutics, Inc.
NCT00477100 N/A
Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Ti...
Condition
Inflammatory Breast Carcinoma
Enrollment
1,200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05800665 Phase 1
Recruiting
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Pa...
Condition
Advanced Prostate Cancer
Enrollment
210 pts
Location
United States, Australia, Canada
Sponsor
Genentech, Inc.
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT05919264 Phase 1, Phase 2
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Condition
Cancer
Enrollment
575 pts
Location
United States
Sponsor
Parabilis Medicines, Inc.
Page 9 of 9 — 219 trials total